Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology  |  Family Medicine  |  Sleep

Search Medical Condition
Please enter condition
Please choose location from dropdown

Sleep Disorders Clinical Trials

A listing of Sleep Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (319) clinical trials

Outpatient study designed to test a new investigational medication in adults 50 years and older with insomnia. Compensation is $1450. To qualify, you must be 50 years and older. Length of study: 4-6 weeks Overnight visits: 5 Total number of outpatient visits: 6 For more information,

Phase N/A

A double-blind randomized, placebo-controlled, 30 night polysomnographic study of an investigational medication in adults 18 and older with primary insomnia. To qualify, you must be: 18 years and older Length of study: 6 weeks Overnight visits: 10 Total number of outpatient visits: 1 For more information,

Phase N/A

This study will evaluate the efficacy of cyclobenzaprine in the treatment of military-related PTSD. The study is randomized and double-blind, meaning both the participant and the tester are unaware which group is receiving the experimental and placebo treatments. The study will last approximately 12 weeks. Participants take the study drug ...

Phase

Primary: To evaluate the efficacy of brexpiprazole as monotherapy or as combination treatment with Zoloft (sertraline) in adult subjects with PTSD. Secondary: To evaluate the safety and tolerability of brexpiprazole 1 to 3 mg/day as monotherapy or as combination treatment with Zoloft (sertraline) in adult subjects with PTSD.

Phase

To evaluate the safety, efficacy and tolerability of brexpiprazole (with placebo) as monotherapy or combination therapy (Zoloft) in adults with PTSD.

Phase

A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1-3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post-traumatic Stress Disorder

Phase

The study is assessing how effective an online tool, personalized bedtime reminders and a baby monitoring system is on infant sleep and the mother's mood, sleep, physiological state and skin condition.

Phase N/A

We want to see if couple's-based therapy reduces Post-Traumatic Stress Disorder (PTSD) symptoms and improves relationships with partners and children.

Phase N/A

Interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose study to evaluate the efficacy of brexpiprazole as adjunctive treatment to paroxetine or sertraline on PTSD symptoms.

Phase